Senior insider sale
GALECTIN THERAPEUTICS INC — senior position signals high conviction
$652.2K
132.08K shares
LEWIS JOEL plans to sell 132.08K shares of GALECTIN THERAPEUTICS INC valued at approximately $652.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Units
Equity Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/1/2026 | Restricted Stock Units Equity Compensation | 84K | — |
| Total | 84K | ||
Completed
Units to sell
7.83K
Market value
$55.2K
Units to sell
6.78K
Market value
$41.7K
Units to sell
15.68K
Market value
$94.6K
Units to sell
1.87K
Market value
$11.3K
Units to sell
200.00
Market value
$1.2K
Units to sell
14.42K
Market value
$87.5K
Units to sell
1.30K
Market value
$7.8K
Planned — Approximate Date
Units to sell
84K
Market value
$352.8K
Units
132.08K
Value
$652.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/17/2025 | 7.83K | $55.2K | — | Completed |
11/18/2025 | 6.78K | $41.7K | — | Completed |
11/17/2025 | 15.68K | $94.6K | — | Completed |
11/10/2025 | 1.87K | $11.3K | — | Completed |
11/5/2025 | 200.00 | $1.2K | — | Completed |
11/4/2025 | 14.42K | $87.5K | — | Completed |
11/3/2025 | 1.30K | $7.8K | — | Completed |
| Planned — Approximate Date | ||||
1/2/2026 | 84K | $352.8K | Nasdaq | Planned |
| Total | 132.08K | $652.2K | ||